Multi-omics clustering analysis carries out the molecular specific subtypes of thyroid carcinoma: implicating for the precise treatment strategies

癌症研究 舒尼替尼 生物 肿瘤科 医学 生物信息学 内科学 癌症
作者
Zhenglin Wang,Qijun Han,Xianyu Hu,Xu Wang,Rui Sun,S.W. Huang,Wei Chen
出处
期刊:medRxiv
标识
DOI:10.1101/2024.02.25.24303184
摘要

Abstract Background Thyroid cancer is the most prevalent endocrine malignancy, Recent classifications highlight the importance of molecular characteristics in TC, including BRAF, TERT, and RET fusion gene mutations, which are crucial for diagnosis, prognosis, and targeted therapy. This study aims to explore molecular subtypes of TC to identify new biomarkers and improve patient selection for targeted therapies. Methods This study utilized multi-omics data from the TCGA-THCA dataset and additional cohorts (GSE29265, GSE33630, GSE54958, GSE65074) involving a total of 539 patients. Various data types, including DNA methylation, gene mutations, mRNA, LncRNA, and miRNA expression, were analyzed. The study employed consensus clustering algorithms to identify molecular subtypes and used various bioinformatics tools to analyze genetic alterations, signaling pathways, immune infiltration, and responses to chemotherapy and immunotherapy. The statistical significance was established at P < 0.05. Results Two prognostically relevant thyroid cancer subtypes, termed CS1 and CS2, were identified. CS2 was associated with a poorer prognosis of shorter progression-free survival times (P < 0.001). CS1 exhibited higher copy number alterations but lower tumor mutation burden (TMB) than CS2. Notably, CS2 showed higher TMB and cytolytic activity scores, suggesting a potential for higher immunogenicity. Different pathway activations were observed between subtypes, with CS2 showing activation in cell proliferation and immune-related pathways. Drug sensitivity analysis indicated CS2’s higher sensitivity to cisplatin, doxorubicin, paclitaxel, and sunitinib, whereas CS1 was more sensitive to bicalutamide and FH535. The different activated pathways and sensitive to drugs for subtypes were further validated in external cohort. After dimensionality reduction, five genes of CXCL17, LCN2, MUC1, SERPINA1, and SLC34A2 were validated that can distinguish subtypes across pan-cohorts. 24 paired tumor and adjacent normal tissues by immunohistochemical staining further show the prognostic value of CXCL17 for advanced thyroid cancer. Conclusion The study revealed two distinct molecular subtypes of thyroid cancer with significant implications for prognosis, genetic alterations, pathway activation, and treatment response. These findings underscore the potential of multi-omics approaches in enhancing personalized medicine in thyroid cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
麒麟才子完成签到,获得积分10
刚刚
觉皇完成签到,获得积分10
刚刚
充电宝的应助被hhhhhhh采纳,获得10
刚刚
相看两厌完成签到,获得积分10
1秒前
吴境发布了新的文献求助10
1秒前
2秒前
2秒前
syvshc的应助被皮卡丘采纳,获得10
2秒前
3秒前
carbon发布了新的文献求助10
3秒前
3秒前
Cat完成签到,获得积分0
4秒前
Mars发布了新的文献求助10
4秒前
KDshyking完成签到,获得积分10
4秒前
KKK完成签到 ,获得积分10
5秒前
dean完成签到,获得积分10
5秒前
腼腆的虔纹完成签到,获得积分20
5秒前
5秒前
哟呵完成签到,获得积分0
6秒前
6秒前
烟花的应助被王淼采纳,获得30
7秒前
柚子完成签到,获得积分10
7秒前
墨之默完成签到,获得积分10
7秒前
7秒前
顾矜的应助被Bubble采纳,获得10
8秒前
8秒前
YXH发布了新的文献求助10
8秒前
9秒前
爽飞边芷了完成签到,获得积分10
9秒前
yyyy完成签到,获得积分20
10秒前
10秒前
Imin完成签到,获得积分10
10秒前
10秒前
黄毛虎发布了新的文献求助10
10秒前
yyp完成签到,获得积分10
11秒前
李旭发布了新的文献求助10
11秒前
Zzj发布了新的文献求助10
12秒前
簪星曳月完成签到,获得积分10
13秒前
HAN发布了新的文献求助30
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187480
求助须知:如何正确求助?哪些是违规求助? 9575554
关于积分的说明 21841909
捐赠科研通 7785230
什么是DOI,文献DOI怎么找? 3434949
关于科研通互助平台的介绍 2559412
邀请新用户注册赠送积分活动 2481898